Related Experiment Video
Updated: Sep 15, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Does early-targeted risk-based management of a patent ductus arteriosus improve outcomes in preterm infants? Insights
Rachel Mullaly1,2, Aisling Smith2, Claire Murphy2
1Department of Paediatrics, Royal College of Surgeons in Ireland, Dublin, Ireland rachelmullaly21@rcsi.ie.
Insights
Early targeted management of patent ductus arteriosus (PDA) in preterm infants using the PDA Severity Score (PDAsc) improved respiratory outcomes in high-risk infants who responded to treatment. Further research is needed to confirm these findings.
Area of Science:
- Neonatal Intensive Care
- Pediatric Cardiology
- Respiratory Medicine
Background:
- Patent ductus arteriosus (PDA) management in preterm infants is critical.
- The EL-Khuffash PDA Severity Score (PDAsc) aids in risk stratification.
- Evaluating early-targeted PDA management strategies is essential.
Purpose of the Study:
- To assess outcomes of an early-targeted PDA management strategy using PDAsc for risk stratification.
- To compare outcomes between high- and low-risk preterm infants under early-targeted treatment versus a historical reference epoch.
Main Methods:
- A single-centre, observational cohort study in a level III NICU.
- Infants born <29 weeks gestation were stratified into high- and low-risk groups using PDAsc.
- Outcomes (CLD, ventilation/oxygen days) were compared between early-targeted treatment and historical reference epochs.
Main Results:
- High-risk infants with successful PDA closure in the early-targeted epoch had fewer ventilation/oxygen days and lower CLD incidence compared to the reference epoch.
- High-risk infants who failed treatment in the early-targeted epoch had similar outcomes to the reference epoch.
- Low-risk infants in both epochs showed comparable favorable outcomes.
Conclusions:
- Early-targeted, risk-based PDA management may improve respiratory outcomes in responsive high-risk preterm infants.
- The observational design limits causal inference; further RCTs are warranted.
- Improved patient selection in future trials is recommended to clarify treatment-outcome relationships.
Background:
This study evaluates the outcomes of an early-targeted patent ductus arteriosus (PDA) management strategy in preterm infants using the EL-Khuffash PDA Severity Score (PDAsc) for risk stratification. The objective was to compare outcomes between high- and low-risk infants from an early-targeted treatment epoch and a historical reference epoch who were risk stratified but did not undergo treatment.
Methods:
We conducted a single-centre, observational cohort study in a level III neonatal intensive care unit. Infants born <29 weeks gestation were stratified into high- and low-risk groups using the PDAsc. High-risk infants in the early-targeted treatment epoch received medical intervention, while low-risk infants did not. Outcomes from this epoch were compared with a historical reference epoch in which risk was assigned but treatment was not implemented. The primary outcomes included chronic lung disease (CLD), ventilation days and oxygen days.
Results:
A total of 110 high-risk and 74 low-risk infants were identified in the early-targeted epoch, compared with 84 high-risk and 51 low-risk infants in the reference epoch. High-risk infants in the early-targeted treatment epoch who achieved successful PDA closure demonstrated fewer ventilation days (median 5 vs 11), fewer oxygen days (median 45 vs 65) and a lower incidence of CLD (59% vs 76%) compared with high-risk infants in the reference epoch. However, high-risk infants in the early-targeted treatment epoch who failed treatment experienced outcomes similar to high-risk infants in the reference epoch. Low-risk infants in both epochs exhibited comparable favourable outcomes.
Conclusions:
The implementation of early-targeted risk-based PDA management may be associated with improved respiratory outcomes in high-risk infants who successfully responded to treatment. However, the observational nature of this study limits causal inferences. These findings underscore the need for further research, including randomised controlled trials with improved patient selection, to better understand the relationship between stratified treatment and important outcomes.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management

